Cargando…
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Despite its enduring relevance as the single most effective and important evidence-based treatment for schizophrenia, underutilization of clozapine remains considerable. To a substantial degree, this is attributable to a reluctance of psychiatrists to offer clozapine due to its relatively large side...
Autores principales: | Qubad, Mishal, Bittner, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041648/ https://www.ncbi.nlm.nih.gov/pubmed/36994117 http://dx.doi.org/10.1177/20451253231158152 |
Ejemplares similares
-
Clozapin-Update 2022
por: Qubad, Mishal, et al.
Publicado: (2022) -
S160. INTERACTIONS BETWEEN BOTTOM-UP AND TOP-DOWN ATTENTION DURING WORKING MEMORY ENCODING: EVALUATION OF AN FMRI PARADIGM FOR THE STUDY OF COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA
por: Qubad, Mishal, et al.
Publicado: (2018) -
Second chances – better than none
por: Liesveld, Jane
Publicado: (2023) -
Clozapine resistant schizophrenia: Newer avenues of management
por: Chakrabarti, Subho
Publicado: (2021) -
Management of patients with Clozapine Resistant Schizophrenia
por: Rajendran*, Nithya Ragavi, et al.
Publicado: (2022)